July 15th 2024
A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.
July 10th 2024
Why these programs require a hybrid approach that combines technology and human connection.
July 9th 2024
An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time.
July 5th 2024
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
July 2nd 2024
A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes.
Barriers Encountered by Patients While Making Cancer Care Clinic Appointments
A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.
The Association Between 340B Program Involvement and Availability of Hospital Services
A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.
Differences in Patient Portal Engagement Among Hypertension Patients
A retrospective study investigates whether use of these portals can be defined by clinical and sociodemographic data.
ProBio Opens New Viral Vector Production Plant in the Garden State
The Hopewell facility—which will serve as the CDMO’s North American hub—is expected to help accelerate the cell and gene therapy delivery process.
Determining the Source of Endocrine Therapy Nonadherence
A retrospective cohort study investigates the characteristics of female patients with localized breast cancer that are associated with this nonpersistence.
Do Medicare Advantage Plans with Supplemental Benefits Result in Better Plan Ratings?
A cohort study explores the connection between the rise in Medicare Advantage plan coverage and enrollee satisfaction.
Combining RWE and AI to Bend the Adherence Curve
By marrying real-world evidence and AI, pharma stakeholders can identify new opportunities to tailor interventions in a way that is most impactful to patients—helping them overcome roadblocks in initiating and maintaining therapy.
How Serious Are You About Patient Centricity?
Companies need to alter their thinking to better prioritize patients. Here are three simple yet impactful engagement elements that could help.
Introducing Emota: A New Inizio Engage Agency
Ashfield Event Experiences and WRG merge in an effort to better serve the healthcare industry.
The Need to Make Telehealth Flexibilities Permanent
If Congress doesn't act soon, it could result in more health inequities.
The Impact of Medicare Part D Antidementia Medication Therapy Management on Adherence
A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.
HealthWell Foundation Unveils Fund to Help Patients Living with MASH
Among its benefits, the fund will provide up to $8,000 in medication copayment or insurance premium assistance.
Walgreens Debuts Specialty Pharma Business
The move features the launch of an innovation center revolving around cell and gene services.
From Toggling Tediously Between Systems to Achieving Whole-Person Care
The rationale behind transforming case management in healthcare.
Evaluating the Long-Term Clinical Benefit of Cancer Treatments Granted Accelerated Approval
A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.
How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease Patients
If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
An 'Access' Double-Take: Fresh Views on PAPs and Patient Hubs
Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.
Does Biosimilar Competition Result in Lower Out-of-Pocket Costs for Patients?
Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics.
The Power of Patient Adherence Tools to Improve the Patient Journey
Why manufacturers should leverage technology to address low adherence rates.
Tackling Patient-Related Challenges Along the Pharma Supply Chain
Syneos Health's Kim Plesnarski uncovers the key issues that customers are currently trying to address, including the retail shift from small-molecule products to biologics.
Fail-First Policies Are Harming Patients
Patients should not have to wait to access the medication they need.
New York City, Los Angeles Will Now Offer Amazon Pharmacy Same-Day Delivery
The new option will help patients receive life-saving medications at an even quicker rate.
Are Adults With Diabetes Who Switch to High-Deductible Health Plans at Greater Risk for Complications?
A study of patients with the long-term conditions who are required to switch to high-deductible health plans could potentially be more likely to experience diabetes complications than those who stay in standard insurance plans.
PAP 2024: Adrianna Nava Discusses Goals of the NAHN
In an interview with Pharma Commerce Associate Editor Don Tracy, Adrianna Nava, PhD, MPA, MSN, RN, President, National Association of Hispanic Nurses (NAHN) talks about the organization's mission and goals.
PAP 2024: The Glass is Half Full
A multiple myeloma survivor shares his story, including how patient assistance made a positive impact.
PAP 2024: Teaming Up on Patient Assistance
Presentation discusses the evolution of the patient assistance landscape, while presenting ways to collaborate.
Hubs East 2024: Leveraging Digital Hubs
Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.
PAP 2024: Embracing the Power of Artificial Intelligence
Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes.
PAP 2024: Examining Patient Access and Affordability
Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.
Access USA 2024: The State of the Industry
Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.